bitBiome, Inc.

📍 新宿区, Japan🗓 Founded 2018👥 53 employees💰 Last funded May 2026
Biotechnology🌐 bitbiome.bio
Website LinkedIn
bitBiome is a synthetic biology company built from their proprietary microbial single-cell microfluidic sequencing technology (bit-MAP). We have spent the last few years building up a large and diverse database (bit-GEM) of over 2 billion microbial sequences (adding additional sequences at a rate of nearly 1 billion per year). bit-GEM draws from many sources including human, animal, and over half coming from environmental samples including soil, seawater and hot springs. bit-GEM therefore offers a unique source of natural enzymes not found in any other private or public sequence library available. Combining bit-GEM with bioinformatics, protein structure analysis tools, and machine learning, we have developed bit-QED, an end-to-end enzyme discovery and development platform. bitBiome offers a range of services from single cell genomics, database screening and shortlisting, to wet lab evaluation of target sequences and directed evolution campaigns. We are also focused on conducting in-house R&D for applications in chemical, food and nutrition, and life science industries. Discover the full potential of microbes with bitBiome today!
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in bitBiome, Inc.?
bitBiome, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did bitBiome, Inc. last raise funding?
The most recent investment in bitBiome, Inc. recorded on gritt.io was in May 2026.
When was bitBiome, Inc. founded?
bitBiome, Inc. was founded in 2018.
What industry is bitBiome, Inc. in?
bitBiome, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is bitBiome, Inc. based?
bitBiome, Inc. is headquartered in 新宿区, Japan.